CompuGroup Stock - analyst consensus and strategy snapshot

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 16:26 CET. Details in the imprint.

CompuGroup Medical (DE000A288904) currently has no new ad-hoc release or major market-moving headline. The stock therefore lends itself to a closer look at the analyst consensus and the firm's longer-term digital-health strategy based on recent publications and filings.

What recent reports show

CompuGroup Medical last presented detailed figures for the 2024 financial year and its 2025 outlook in its annual reporting and subsequent quarterly updates, emphasizing recurring revenues from practice and clinic software as a key earnings driver according to its published investor materials.

The company highlighted continued demand for digital solutions in healthcare IT, from electronic patient records to telematics infrastructure services, and pointed to growth opportunities in Germany and other European markets based on its recent strategic presentations on the investor-relations site.

Analyst views and consensus today

On the analyst side, major houses that actively cover European mid-cap technology and health-IT names have updated their views in recent months, and data aggregators summarizing these publications indicate a mixed but generally constructive stance on CompuGroup Medical’s earnings trajectory and balance between growth investments and cash generation.

Overall, the available consensus snapshots compiled from recent analyst notes show a distribution that includes Buy and Hold ratings, reflecting expectations of steady recurring revenue but also awareness of regulatory and reimbursement uncertainties in national health systems.

How the company makes money

CompuGroup Medical generates most of its revenue from software and IT services for doctors’ practices, pharmacies, laboratories and hospitals, including practice management systems and clinical information systems sold on license and subscription models, along with related maintenance, hosting and support services.

Where the stock trades today

The shares of CompuGroup Medical (DE000A288904) trade on Xetra at EUR 32.50 as of 06/17/2026, 16:20 CET.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.